These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12384828)

  • 21. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial.
    Nanditha A; Thomson H; Susairaj P; Srivanichakorn W; Oliver N; Godsland IF; Majeed A; Darzi A; Satheesh K; Simon M; Raghavan A; Vinitha R; Snehalatha C; Westgate K; Brage S; Sharp SJ; Wareham NJ; Johnston DG; Ramachandran A
    Diabetologia; 2020 Mar; 63(3):486-496. PubMed ID: 31919539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mobile Delivery of the Diabetes Prevention Program in People With Prediabetes: Randomized Controlled Trial.
    Toro-Ramos T; Michaelides A; Anton M; Karim Z; Kang-Oh L; Argyrou C; Loukaidou E; Charitou MM; Sze W; Miller JD
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e17842. PubMed ID: 32459631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of a self-management intervention with personalised genetic and lifestyle-related risk information on coronary heart disease and diabetes-related risk in type 2 diabetes (CoRDia): study protocol for a randomised controlled trial.
    Davies AK; McGale N; Humphries SE; Hirani SP; Beaney KE; Bappa DA; McCabe JG; Newman SP
    Trials; 2015 Dec; 16():547. PubMed ID: 26631181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioural interventions for type 2 diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(21):1-45. PubMed ID: 23074526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial.
    Suppapitiporn S; Chindavijak B; Onsanit S
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S134-41. PubMed ID: 16623018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Aiello LP;
    Diabetes Care; 2014; 37(1):17-23. PubMed ID: 24356593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT.
    Khunti K; Griffin S; Brennan A; Dallosso H; Davies M; Eborall H; Edwardson C; Gray L; Hardeman W; Heathcote L; Henson J; Morton K; Pollard D; Sharp S; Sutton S; Troughton J; Yates T
    Health Technol Assess; 2021 Dec; 25(77):1-190. PubMed ID: 34995176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifestyle changes and glycemic control in type 1 diabetes mellitus: a trial protocol with factorial design approach.
    Sawani S; Siddiqui AR; Azam SI; Humayun K; Ahmed A; Habib A; Naz S; Tufail M; Iqbal R
    Trials; 2020 Apr; 21(1):346. PubMed ID: 32312302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of lifestyle education program for type 2 diabetes patients in clinics: a cluster randomized controlled trial.
    Adachi M; Yamaoka K; Watanabe M; Nishikawa M; Kobayashi I; Hida E; Tango T
    BMC Public Health; 2013 May; 13():467. PubMed ID: 23672733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study Protocol: The Norfolk Diabetes Prevention Study [NDPS]: a 46 month multi - centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with Type 2 diabetes] to prevent transition to Type 2 diabetes in high risk groups with non - diabetic hyperglycaemia, or impaired fasting glucose.
    Pascale M; Murray N; Bachmann M; Barton G; Clark A; Howe A; Greaves C; Sampson M
    BMC Public Health; 2017 Jan; 17(1):31. PubMed ID: 28056894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Act on Threes" Paradigm for Treatment Intensification of Type 2 Diabetes in Managed Care: Results of a Randomized Controlled Study with an Educational Intervention Targeting Improved Glycemic Control.
    Bieszk N; Reynolds SL; Wei W; Davis C; Kamble P; Uribe C
    J Manag Care Spec Pharm; 2016 Sep; 22(9):1028-38. PubMed ID: 27579824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of glucose control.
    Edelman SV
    Med Clin North Am; 1998 Jul; 82(4):665-87. PubMed ID: 9706116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Head-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an assessor-blinded, parallel group and randomised trial.
    Ried-Larsen M; Christensen R; Hansen KB; Johansen MY; Pedersen M; Zacho M; Hansen LS; Kofoed K; Thomsen K; Jensen MS; Nielsen RO; MacDonald C; Langberg H; Vaag AA; Pedersen BK; Karstoft K
    BMJ Open; 2015 Dec; 5(12):e009764. PubMed ID: 26656025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycemic and non-glycemic targets in younger and older North Indian subjects with type 2 diabetes in a Tertiary care hospital: A 10 year's retrospective data analysis.
    Ahmad J; Zubair M; Malik N; D Z; Raghav A
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S130-4. PubMed ID: 26564028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.